Wassermann test

A sample of blood or cerebrospinal fluid is taken and introduced to the antigen, cardiolipin extracted from bovine muscle or heart. Syphilis non-specific antibodies (reagin, see RPR) react with the lipid, the Wassermann reaction of antiphospholipid antibodies (APAs). The intensity of the reaction (classed 1, 2, 3, or 4) indicates the severity of the condition.

The reaction is not specific to syphilis and will produce a positive reaction to other diseases, including systemic lupus erythematosus, malaria, and tuberculosis. It is possible for an infected individual to produce no reaction and for a successfully treated individual to continue to produce a reaction (known as being "Wassermann fast" or "fixed").

The Wassermann test is ineffective at identifying primary syphilis as sufficient reagin has not yet been produced from tissue destruction at this stage. Therefore, more effective methods have been a common research topic.

The antibody test was developed by Wassermann, Julius Citron, and Albert Neisser at the Robert Koch Institute for Infectious Diseases in 1906. The test was a growth from the work of Bordet and Gengou on complementing-fixation reaction, published in 1901, and the positive reaction is sometimes called the Bordet-Gengou-Wassermann reaction or Bordet-Wassermann reaction.

The Wassermann test has been refined with the Kahn test and the Kolmer test, and it is rarely used today. Replacement tests such as the VDRL test and the RPR test, initially based on flocculation techniques (Hinton), have been shown to produce far fewer false positive results. Indeed, the "biologic false positives" of modern tests usually indicate a serious alternate condition, often an autoimmune disease.